Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions

Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions

The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Monjotin, Nicolas, Le Grand, Bruno, Junquero, Didier
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Monjotin, Nicolas
Le Grand, Bruno
Junquero, Didier
description The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9980970B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9980970B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9980970B23</originalsourceid><addsrcrecordid>eNqNijEOwjAQBNNQIOAP94GIAAW4BASiREDqyHLO4STrzrKPvB-DeADV7uzstKI2I4iH6_5Wr8Cy2kGYsmbwkiAmHJGVeCiqX5ZFE9ovRwwj1RETMdoA_sVOSbjUaPUpQQZyBZxwTx-R59XE25Bx8ctZBefT43ipMUqHOVqHjNq1d2N2jdk2h_Xmj8sbneRArw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions</title><source>esp@cenet</source><creator>Monjotin, Nicolas ; Le Grand, Bruno ; Junquero, Didier</creator><creatorcontrib>Monjotin, Nicolas ; Le Grand, Bruno ; Junquero, Didier</creatorcontrib><description>The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180529&amp;DB=EPODOC&amp;CC=US&amp;NR=9980970B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25573,76557</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180529&amp;DB=EPODOC&amp;CC=US&amp;NR=9980970B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Monjotin, Nicolas</creatorcontrib><creatorcontrib>Le Grand, Bruno</creatorcontrib><creatorcontrib>Junquero, Didier</creatorcontrib><title>Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions</title><description>The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNijEOwjAQBNNQIOAP94GIAAW4BASiREDqyHLO4STrzrKPvB-DeADV7uzstKI2I4iH6_5Wr8Cy2kGYsmbwkiAmHJGVeCiqX5ZFE9ovRwwj1RETMdoA_sVOSbjUaPUpQQZyBZxwTx-R59XE25Bx8ctZBefT43ipMUqHOVqHjNq1d2N2jdk2h_Xmj8sbneRArw</recordid><startdate>20180529</startdate><enddate>20180529</enddate><creator>Monjotin, Nicolas</creator><creator>Le Grand, Bruno</creator><creator>Junquero, Didier</creator><scope>EVB</scope></search><sort><creationdate>20180529</creationdate><title>Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions</title><author>Monjotin, Nicolas ; Le Grand, Bruno ; Junquero, Didier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9980970B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Monjotin, Nicolas</creatorcontrib><creatorcontrib>Le Grand, Bruno</creatorcontrib><creatorcontrib>Junquero, Didier</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Monjotin, Nicolas</au><au>Le Grand, Bruno</au><au>Junquero, Didier</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions</title><date>2018-05-29</date><risdate>2018</risdate><abstract>The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3-(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US9980970B2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-01T04%3A57%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Monjotin,%20Nicolas&rft.date=2018-05-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9980970B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true